Thursday, January 24, 2013

Valley surgeon heads up test of aneurysm treatment - Business Courier of Cincinnati:

aleksanovlsys.blogspot.com
Rodriguez, the director of peripheral vasculare services at the ArizonwaHeart Institute, has been named the nationaol principal investigator for the Phase II study, whic h is required by the to enroll 160 patients. The Arizon a Heart Institute is one of 14 centers involved in thestudg nationwide. “We are looking to includer at least six more centers to complete 20 centersd inthe U.S.,” Rodriguea said. The endoluminal graft is manufactured bynear Glasgow, Scotland. Callex the Anaconda Stent Graft System, it allows the surgeomn to reposition the device once it has been placedx acrossthe aneurysm.
So far, nearlh 4,000 patients in Europe have received theAnaconda device, but it must get approval from the FDA beforw it can be used in the U.S. Rodriguez said the minimally invasive procedure onthe study’s firsr patient went well, saying the device is very easy to use. “He was up on his feet the next morninghavingv breakfast,” Rodriguez said of the “You can’t do that when you open the This eliminates the need for open heart Abdominal aortic aneurysm, or “ballooning” of the body’sw main artery, is a serious conditioh prone to rupture and lead to sudden Actor John Ritter died of an aortic rupture in 2003.
Symptoms can occue suddenly with severe, sharp pain in the abdomen. Patientsw who experience these symptoms should seek immediate medical Rodriguez said. Early detectio can prevent sudden death. Patients with a family history of aorticd aneurysm or other connective tissue disorders should notifyh their physician about their risk ofaorticc aneurysm, he said.

No comments:

Post a Comment